Pain Research and Management (Jan 2014)

Pharmacological Management of Chronic Neuropathic Pain: Revised Consensus Statement from the Canadian Pain Society

  • DE Moulin,
  • A Boulanger,
  • AJ Clark,
  • H Clarke,
  • T Dao,
  • GA Finley,
  • A Furlan,
  • I Gilron,
  • A Gordon,
  • PK Morley-Forster,
  • BJ Sessle,
  • P Squire,
  • J Stinson,
  • P Taenzer,
  • A Velly,
  • MA Ware,
  • EL Weinberg,
  • OD Williamson

DOI
https://doi.org/10.1155/2014/754693
Journal volume & issue
Vol. 19, no. 6
pp. 328 – 335

Abstract

Read online

BACKGROUND: Neuropathic pain (NeP), redefined as pain caused by a lesion or a disease of the somatosensory system, is a disabling condition that affects approximately two million Canadians.